Shamburg News · 8-K filed Nov 10, 2026, 8:05 AM EST
PDS Biotechnology Says NantWorks Exercised Warrants for About $3.9 Million in Gross Proceeds
PDSB · PDS Biotechnology Corp
- Financing
- Other event
- Materiality: medium
On November 10, 2026, PDS Biotechnology Corporation announced that NantWorks exercised outstanding common stock warrants for an aggregate of 17,699,115 shares (or pre-funded warrants in lieu thereof) at an exercise price of $0.22 per share. The gross proceeds to the Company from the exercise were approximately $3.9 million. Shares issued on exercise are unregistered, and the portion exceeding a 19.9% beneficial ownership limitation was exercised into pre-funded warrants at $0.00033 per share.
Source: SEC EDGAR, Form 8-K, Items 8.01, 9.01, accession 0001140361-26-042898.
Written from the filing by Shamburg Markets. Figures are as reported by the company.